| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 113,947 | 112,393 | 113,120 | 114,908 | | Cost of Revenue | 43,818 | 85,523 |
-
| 43,210 | | | Gross Profit | 70,129 | 26,870 | 113,120 | 71,698 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 51,650 | 1,094 | 85,692 | 36,855 | | Non Recurring |
-
|
-
|
-
| 906 | | Others |
-
|
-
|
-
| 8,756 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,479 | 25,776 | 27,428 | 25,181 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 2,246 | | Earnings Before Interest And Taxes | 18,479 | 25,776 | 27,428 | 27,427 | | Interest Expense |
-
|
-
|
-
| 4,221 | | Income Before Tax | 18,479 | 25,776 | 27,428 | 23,206 | | Income Tax Expense | 7,648 | 9,985 | 10,327 | 8,474 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,831 | 15,791 | 17,101 | 14,732 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,831 | 15,791 | 17,101 | 14,732 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,831 | $15,791 | $17,101 | $14,732 |
|
0.31% Nasdaq 0.00%
Income Statement
